These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10731227)

  • 21. Prefrontal cortical BDNF: A regulatory key in cocaine- and food-reinforced behaviors.
    Pitts EG; Taylor JR; Gourley SL
    Neurobiol Dis; 2016 Jul; 91():326-35. PubMed ID: 26923993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of an excitatory amino acid-mediated component of the ventral tegmental area local field potential response to medial prefrontal cortex stimulation: effect of acute d-amphetamine.
    Dommett EJ; Simpson J; Clark D; Overton PG
    J Neural Transm (Vienna); 2007 Feb; 114(2):161-72. PubMed ID: 16897608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orbitofrontal cortex, decision-making and drug addiction.
    Schoenbaum G; Roesch MR; Stalnaker TA
    Trends Neurosci; 2006 Feb; 29(2):116-24. PubMed ID: 16406092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased corticolimbic connectivity in cocaine dependence versus pathological gambling is associated with drug severity and emotion-related impulsivity.
    Contreras-Rodríguez O; Albein-Urios N; Vilar-López R; Perales JC; Martínez-Gonzalez JM; Fernández-Serrano MJ; Lozano-Rojas O; Clark L; Verdejo-García A
    Addict Biol; 2016 May; 21(3):709-18. PubMed ID: 25818325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered neural response of the appetitive emotional system in cocaine addiction: an fMRI Study.
    Asensio S; Romero MJ; Palau C; Sanchez A; Senabre I; Morales JL; Carcelen R; Romero FJ
    Addict Biol; 2010 Oct; 15(4):504-16. PubMed ID: 20579005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medial prefrontal cortex in neurological diseases.
    Xu P; Chen A; Li Y; Xing X; Lu H
    Physiol Genomics; 2019 Sep; 51(9):432-442. PubMed ID: 31373533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific abnormalities in serotonin release in the prefrontal cortex of isolation-reared rats measured during behavioural performance of a task assessing visuospatial attention and impulsivity.
    Dalley JW; Theobald DE; Pereira EA; Li PM; Robbins TW
    Psychopharmacology (Berl); 2002 Nov; 164(3):329-40. PubMed ID: 12424557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medial prefrontal cortex inactivation attenuates the diurnal rhythm in amphetamine reward.
    Baltazar RM; Coolen LM; Webb IC
    Neuroscience; 2014 Jan; 258():204-10. PubMed ID: 24239716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cocaine addiction as a neurological disorder: implications for treatment.
    Majewska MD
    NIDA Res Monogr; 1996; 163():1-26. PubMed ID: 8809851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of cocaine self-administration on learning related to prefrontal cortex or hippocampus functioning in rats.
    Kantak KM; Udo T; Ugalde F; Luzzo C; Di Pietro N; Eichenbaum HB
    Psychopharmacology (Berl); 2005 Sep; 181(2):227-36. PubMed ID: 15830232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glial and neuroinflammatory targets for treating substance use disorders.
    Bachtell RK; Jones JD; Heinzerling KG; Beardsley PM; Comer SD
    Drug Alcohol Depend; 2017 Nov; 180():156-170. PubMed ID: 28892721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of prefrontal cortex in the extinction of drug memories.
    Zhang WH; Cao KX; Ding ZB; Yang JL; Pan BX; Xue YX
    Psychopharmacology (Berl); 2019 Jan; 236(1):463-477. PubMed ID: 30392133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered prefrontal dopaminergic function in chronic recreational ketamine users.
    Narendran R; Frankle WG; Keefe R; Gil R; Martinez D; Slifstein M; Kegeles LS; Talbot PS; Huang Y; Hwang DR; Khenissi L; Cooper TB; Laruelle M; Abi-Dargham A
    Am J Psychiatry; 2005 Dec; 162(12):2352-9. PubMed ID: 16330601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of repeated cocaine on medial prefrontal cortical GABAB receptor modulation of neurotransmission in the mesocorticolimbic dopamine system.
    Jayaram P; Steketee JD
    J Neurochem; 2004 Aug; 90(4):839-47. PubMed ID: 15287889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cortico-basal ganglia circuits involved in different motivation disorders in non-human primates.
    Sgambato-Faure V; Worbe Y; Epinat J; Féger J; Tremblay L
    Brain Struct Funct; 2016 Jan; 221(1):345-64. PubMed ID: 25304400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pretreated rats.
    Acquas E; Tanda G; Di Chiara G
    Neuropsychopharmacology; 2002 Aug; 27(2):182-93. PubMed ID: 12093592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic cocaine reduces RGS4 mRNA in rat prefrontal cortex and dorsal striatum.
    Schwendt M; Hearing MC; See RE; McGinty JF
    Neuroreport; 2007 Aug; 18(12):1261-5. PubMed ID: 17632279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S; Harvey BH
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential impact of severity of drug use on frontal behavioral symptoms.
    Verdejo-García A; Rivas-Pérez C; López-Torrecillas F; Pérez-García M
    Addict Behav; 2006 Aug; 31(8):1373-82. PubMed ID: 16326022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights to drug addiction derived from ultrastructural views of the mesocorticolimbic system.
    Morales M; Pickel VM
    Ann N Y Acad Sci; 2012 Feb; 1248():71-88. PubMed ID: 22171551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.